Australian clot-busting drug holds hope for COVID-19 treatment


  • World
  • Friday, 12 Jun 2020

FILE PHOTO: A nurse checks a patient's temperature in a coronavirus disease (COVID-19) testing clinic at Westmead Hospital in Sydney, Australia, May 12, 2020. REUTERS/Loren Elliott

SYDNEY (Reuters) - An experimental drug developed by an Australian researcher could help prevent deaths from COVID-19 by controlling the formation of blood clots responsible for breathing difficulties, organ failure, stroke and heart attack.

Professor Shaun Jackson from the University of Sydney and the Heart Research Institute is leading a team of researchers developing a new anti-clotting medicine to treat stroke.

Get 30% off with our ads free Premium Plan

Monthly Plan

RM9.73/month

Annual Plan

RM8.63/month

Billed as RM103.60/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Apple cancels work on electric car, ending decade-long effort
Honduras moves to exit World Bank arbitration body
Factbox-What causes Bangladesh's major industrial accidents?
Russia ready to hand over crash victims' bodies to Ukraine, RIA says
Man uses hidden cameras disguised as clocks to record dogsitter, other women, US cops say
‘Pig-butchering’ scams net more than RM355bil, study finds
Nintendo sues company for piracy on ‘colossal scale’
Vietnam eyes crackdown on workers rights, foreign aid, report says
Some US lawmakers urge Biden, Blinken not to recognize new Pakistan government
Palestinians say Israeli troops fired at people seeking food

Others Also Read